Focus novembre-dicembre 2015
Italiano
Discoloration is indicative of degradation and could result in decreased potency due to oxidation of norepinephrine bitartrate.
Error may result in inappropriate treatment of a patient’s infection and could cause serious health consequences, including increased time in the hospital, unnecessary tests or procedures, treatment failure, sepsis, and even death.
L'Agenzia Italiana del Farmaco rende disponibili importanti
informazioni di sicurezza correlate alla tollerabilità epatica di Viekirax (ombitasvir, paritaprevir, ritonavir) con o senza Exviera (dasabuvir).
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti raccomandazioni in merito a recenti modifiche delle informazioni sul medicinale Gilenya (fingolimod) relative agli effetti immunosoppressivi.
The FDA reviewed the revised reprocessing instructions and the validation data and determined they meet the Agency’s expectations.
If this occurs, ventilation may fail and the patient may not receive either anesthesia or enough oxygen.
Risk of increased blood pressure and/or pulse rate may present significant risk for patients with a history of CAD, CHF, arrhythmias or
stroke. Potentially serious GI disturbances, irregular heartbeat, and cancer with long-term use.
Risk of increased blood pressure and/or pulse rate may present significant risk for patients with a history of CAD, CHF, arrhythmias or
stroke. Potentially serious GI disturbances, irregular heartbeat, and cancer with long-term use.
Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels that may be life threatening.
80.211.154.110